Clinical Trials Sponsored by John B. Amos Cancer Center

Total 1216 results

Travera Inc
John B. Amos Cancer Center

Not yet recruiting

Defining the Clinical Potential of Mass Response as a Biomarker for Patient Tumor Sensitivity to Drugs

Carcinoma, Renal Cell | Carcinoma | Carcinoma, Non-Small-Cell Lung | Carcinoma, Hepatocellular | Carcinoma, Pancreatic | Mesothelioma | AML | Cholangiocarcinoma | Stage IV Lung Cancer | Carcinoma, Neuroendocrine | Stage IV Breast Cancer | Carcinoma, Ductal | Malignant Ascites | Carcinoma Prostate | Stage III Breast Cancer and other conditions

United States
Amos Yinnon

Completed

The Risk for Clostridium Difficile Colitis During Hospitalization in Asymptomatic Carriers

Colitis | Clostridium Difficile

Israel
Ohio State University Comprehensive Cancer Center
Cancer and Leukemia Group B

Completed

Omega-3 Fatty Acids in Preventing Joint Symptoms in Patients With Stage I-III Breast Cancer Receiving Anastrozole, Exemestane, or Letrozole

Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast Cancer

United States
Memorial Sloan Kettering Cancer Center
Joan Karnell Cancer Center at Pennsylvania

Active, not recruiting

A Pilot Study of Geriatric Specific Interventions for Quality of Life in Elderly Patients With Cancer

Breast Cancer | Lung Cancer | Prostate Cancer | Gynecological Cancers | Lymphoma Cancer

United States
Sidney Kimmel Comprehensive Cancer Center at Johns...
The John P. Hussman Foundation

Completed

Safety Study of a Melanoma Vaccine (GVAX) With or Without Cyclophosphamide in Patients With Surgically Resected Melanoma

Melanoma

United States
John Stoddard Cancer Center at Iowa Methodist Medical...

Unknown

Gene Therapy in Treating Women With Refractory or Relapsed Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer

Ovarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cavity Cancer

United States
John Reneau

Active, not recruiting

Brentuximab Vedotin and Lenalidomide in Treating Patients With Stage IB-IVB Relapsed or Refractory T-Cell Lymphoma

Recurrent T-Cell Non-Hodgkin Lymphoma | Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | Stage III Cutaneous T-Cell Non-Hodgkin Lymphoma | Stage IV Cutaneous T-Cell Non-Hodgkin Lymphoma | Primary Cutaneous Anaplastic Large Cell Lymphoma | Refractory Primary Cutaneous T-Cell Non-Hodgkin... and other conditions

United States
John Reneau

Recruiting

Ruxolitinib for the Treatment of T-Cell Large Granular Lymphocytic Leukemia

T-Cell Large Granular Lymphocyte Leukemia

United States
John Reneau

Recruiting

Third-Party Natural Killer Cells and Mogamulizumab for the Treatment of Relapsed or Refractory Cutaneous T-cell Lymphomas or Adult T-Cell Leukemia/Lymphoma

Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | Recurrent Adult T-Cell Leukemia/Lymphoma | Refractory Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | Refractory Adult T-Cell Leukemia/Lymphoma

United States
John Byrd

Completed

Etanercept and Rituximab in Patients With Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma

Chronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma

United States
Memorial Sloan Kettering Cancer Center
Queens Health Network; CHARLES B WANG COMMUNITY HEALTH CENTER; Cancer Support...

Withdrawn

Developing Culturally-Tailored Information-Based Support Groups for Chinese Immigrants With Breast Cancer

Chinese Immigrants With Breast Cancer

United States
Duke University
Cancer and Leukemia Group B; Durham VA Medical Center

Completed

p16 Methylation for Smoking Cessation

Smoking Cessation | Tobacco Use Disorder | Lung Cancer

United States
Atos Medical AB
The Netherlands Cancer Institute

Completed

Clinical Feasibility of a New Voice Prosthesis

Laryngectomy

Netherlands
Atos Medical AB
The Netherlands Cancer Institute

Completed

Short-term Clinical Feasibility of the New Provox Vega 22.5 Voice Prosthesis

Total Laryngectomy

Netherlands
Atos Medical AB
The Netherlands Cancer Institute

Completed

Long Term Use of the Provox Vega 22.5

Total Laryngectomy

Netherlands
Atos Medical AB
The Netherlands Cancer Institute

Completed

Short-term Clinical Feasibility of the Provox XtraHMEs for Pulmonary Rehabilitation After Total Laryngectomy (N08HME)

Total Laryngectomy

Netherlands
Memorial Sloan Kettering Cancer Center
Johns Hopkins University; M.D. Anderson Cancer Center

Completed

A Multicenter Trial On The Utility and Impact Of Computed Tomography and Serum CA-125 In the Management of Newly Diagnosed Ovarian Cancer

Ovarian Cancer

United States
Atos Medical AB
The Netherlands Cancer Institute

Terminated

Long-term Clinical Feasibility of the New Indwelling Provox Vega 20 Voice Prosthesis

Total Laryngectomy

Netherlands
Johns Hopkins University
M.D. Anderson Cancer Center

Withdrawn

Study of High-Dose Oral Vitamin D for the Prevention of Liver Cancer

Hepatocellular Carcinoma | Cirrhosis

United States
John Hays
Amgen

Unknown

Panitumumab and Chemotherapy in Patients With Advanced Colorectal Cancer After Prior Therapy With Bevacizumab

Mucinous Adenocarcinoma of the Rectum | Signet Ring Adenocarcinoma of the Rectum | Mucinous Adenocarcinoma of the Colon | Signet Ring Adenocarcinoma of the Colon | Stage IV Colon Cancer | Stage IV Rectal Cancer | Recurrent Colon Cancer | Recurrent Rectal Cancer

United States
John Hays
Sanofi

Unknown

Aflibercept and FOLFOX6 Treatment for Previously Untreated Stage IV Colorectal Cancer

Mucinous Adenocarcinoma of the Rectum | Signet Ring Adenocarcinoma of the Rectum | Mucinous Adenocarcinoma of the Colon | Signet Ring Adenocarcinoma of the Colon | Stage IV Colon Cancer | Stage IV Rectal Cancer

United States
John Grecula
National Comprehensive Cancer Network

Completed

Bendamustine and Radiation Therapy in Treating Patients With Brain Metastases Caused by Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific | Metastatic Cancer

United States
Yale University
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; Massey Cancer Center

Withdrawn

Study of Volasertib and Belinostat in Patients With Relapsed and Refractory Aggressive B-cell and T-cell Lymphomas

Lymphoma | Relapsed and Refractory Aggressive B- and T-cell Lymphomas

United States
Sidney Kimmel Comprehensive Cancer Center at Johns...
National Comprehensive Cancer Network; Vanderbilt-Ingram Cancer Center

Terminated

A Phase I/II Study Afatinib/Carboplatin/Paclitaxel Induction Chemotherapy In HPV-Negative HNSCC.

Squamous Cell Carcinoma of the Head and Neck

United States
National Cancer Institute (NCI)
Cancer and Leukemia Group B

Completed

Phase III Comparison of Adjuvant Chemotherapy W/High-Dose Cyclophosphamide Plus Doxorubicin (AC) vs Sequential Doxorubicin Fol by Cyclophosphamide (A-C) in High Risk Breast Cancer Patients With 0-3 Positive Nodes (Intergroup, CALGB 9394)

Breast Cancer | High Risk | Cyclophosphamide | Positive Nodes | Doxorubicin

United States
National Cancer Institute (NCI)
Cancer and Leukemia Group B

Completed

Imatinib Mesylate in Treating Patients With Recurrent Small Cell Lung Cancer

Recurrent Small Cell Lung Cancer

United States
Atos Medical AB
Instituto de Cancer Dr Arnaldo

Not yet recruiting

Long Term Effects of Heat and Moisture Exchangers (HMEs)

Laryngectomy; Status

Brazil
Dana-Farber Cancer Institute
Cancer and Leukemia Group B

Active, not recruiting

The Active After Cancer Trial (AACT) (AACT)

Breast Cancer | Colorectal Cancer

United States
Cancer and Leukemia Group B
National Cancer Institute (NCI)

Unknown

Studying Changes in Breast Density in Patients With Early-Stage Breast Cancer Treated With Metformin Hydrochloride or Placebo on CAN-NCIC-MA.32

Breast Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns...

Not yet recruiting

Stereotactic Body Proton Therapy for Treatment of Primary Renal Cell Carcinoma (SPARE)

Renal Cell Carcinoma
Sidney Kimmel Comprehensive Cancer Center at Johns...

Recruiting

PET Dynamics to Response-Adapted Neoadjuvant Therapy in TNBC (NeoADAPT)

Triple Negative Breast Cancer

United States
Sidney Kimmel Comprehensive Cancer Center at Johns...

Not yet recruiting

Exercise in Prostate Cancer

Prostate Cancer | Prostate Cancer Metastatic
Sidney Kimmel Comprehensive Cancer Center at Johns...

Recruiting

Mirdametinib Monotherapy in Adults With Neurofibromatosis 1 (NF1) and Cutaneous Neurofibromas (cNF). (Mirda)

Cutaneous Neurofibroma | NF1 | Monotherapy

United States
Sidney Kimmel Comprehensive Cancer Center at Johns...

Not yet recruiting

Surgical Resection of Synchronous Pulmonary or Hepatic Oligometastatic Pancreatic Ductal Adenocarcinoma

Pancreatic Ductal Adenocarcinoma | Oligometastatic Disease

United States
Sidney Kimmel Comprehensive Cancer Center at Johns...

Recruiting

Prophylactic Peptide Vaccine in Advanced ALK+ NSCLC

NSCLC Stage IV | ALK Fusion Protein Expression

United States
Sidney Kimmel Comprehensive Cancer Center at Johns...

Recruiting

Cardiometabolic Screening Program

Breast Cancer | Early-stage Breast Cancer

United States
Sidney Kimmel Comprehensive Cancer Center at Johns...

Recruiting

Proton Pencil Beam Scanning GRID for Treatment of Bulky Tumors (ProGRID)

Melanoma | Sarcoma

United States
Sidney Kimmel Comprehensive Cancer Center at Johns...

Recruiting

Breath-Hold Technique for Pancreatic Stereotactic Body Radiation Therapy (SBRT) Patients

Pancreas Cancer

United States
Sidney Kimmel Comprehensive Cancer Center at Johns...

Recruiting

Bipolar Androgen Therapy (BAT) and Radium-223 (RAD) in Metastatic Castration-resistant Prostate Cancer (mCRPC) (BAT-RAD)

Prostate Adenocarcinoma | Metastatic Prostate Adenocarcinoma | Castration-resistant

United States, Brazil
Sidney Kimmel Comprehensive Cancer Center at Johns...

Recruiting

Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases

Brain Metastases

United States
Sidney Kimmel Comprehensive Cancer Center at Johns...

Recruiting

Study of Stereotactic Radiotherapy for Breast Cancer

Breast Cancer

United States
Sidney Kimmel Comprehensive Cancer Center at Johns...

Recruiting

MRI for Assessing Prostate Cancer Response (NA_00067284)

Prostate Cancer

United States
Sidney Kimmel Comprehensive Cancer Center at Johns...

Active, not recruiting

Palliative Stereotactic Radiation for Pancreatic or Periampullary Adenocarcinoma

Pancreatic Cancer | Periampullary Adenocarcinoma

United States
Sidney Kimmel Comprehensive Cancer Center at Johns...

Terminated

Combined Aerobic and Resistance Exercise Training in Metastatic Renal Cell Carcinoma

Renal Cell Carcinoma Metastatic

United States
Sidney Kimmel Comprehensive Cancer Center at Johns...

Withdrawn

A Neoadjuvant Study of Abiraterone Acetate, Leuprolide Acetate, and Belzutifan in Men With Regional Prostate Cancer (J2258)

Prostate Cancer
Memorial Sloan Kettering Cancer Center
Sohn Conference Foundation

Active, not recruiting

Game-Based Physical Activity in Childhood Cancer Survivors

Survivors of Childhood Cancer

United States
Sidney Kimmel Comprehensive Cancer Center at Johns...

Terminated

Sex-Mismatched Allogeneic Bone Marrow Transplantation for Men With Metastatic Castration-Resistant Prostate Cancer

Prostate Cancer

United States
Sidney Kimmel Comprehensive Cancer Center at Johns...

Terminated

Camostat With Bicalutamide for COVID-19 (COMBO)

Coronavirus Infection | Covid19 | SARS-CoV Infection

United States
Sidney Kimmel Comprehensive Cancer Center at Johns...

Completed

Low Dose Radiation Therapy for Glioblastoma Multiforme

High Grade Glioma

United States
Sidney Kimmel Comprehensive Cancer Center at Johns...

Completed

A Study of Definitive Therapy to Treat Prostate Cancer (oligo-mets)

Prostate Cancer

United States

Clinical Trials Sponsored by John B. Amos Cancer Center

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Saudi Arabia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations